| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 29, 2022 | Post-IPO Equity | $29.30M | — | — | — | Detail |
| Jun 27, 2022 | Post-IPO Debt | $125M | 1 | Patient Square Capital | — | Detail |
| Oct 15, 2020 | IPO | $141.30M | — | — | — | Detail |
| Jul 29, 2020 | Series E | $81.57M | 5 | Gilde Healthcare , Longitude Capital | — | Detail |
| Mar 5, 2019 | Series D | $52M | 5 | Future Fund | — | Detail |
| Oct 19, 2017 | Series C | $45M | 5 | Nan Fung Life Sciences | — | Detail |
| Jul 26, 2016 | Convertable Note | — | 1 | — | — | Detail |
| Dec 9, 2015 | Series B | $25M | 5 | New Enterprise Associates | — | Detail |
| Jun 25, 2015 | Series A | $13.60M | 9 | Maveron | — | Detail |
| Jul 28, 2014 | Series A | — | 1 | — | — | Detail |
| Oct 9, 2013 | Series A | — | 1 | — | — | Detail |